logo-loader
viewTHC Global Group Ltd

THC Global starts manufacturing at Southport facility after green light from regulator

THC Global Group Ltd’s (ASX:THC) group chief executive officer Ken Charteris updates Proactive after the company received a key medicinal cannabis manufacture permit for its Southport facility from the Australia regulator, allowing production to start immediately.

Charteris says this is a major milestone for the company and will support around 250,000 Australian patients as well as the export market. 

THC Global now has the largest extraction capacity for medicinal cannabis in Australia, with a commercial launch anticipated in early 2020.

Quick facts: THC Global Group Ltd

Price: 0.365 AUD

ASX:THC
Market: ASX
Market Cap: $51.38 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

3 weeks, 3 days ago

2 min read